Gracivask Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Amlodipine besylate

Indications/Uses

HTN. Myocardial ischemia.

Dosage/Direction for Use

HTN Initially 5 mg once daily. Max: 10 mg. Patient w/ low body wt, debility, renal insufficiency, elderly Initially 2.5 mg once daily. Stable or vasospastic angina 5-10 mg daily.

Administration

May be taken with or without food.

Contraindications

Sensitivity to dihydropyridine.

Special Precautions

Kidney failure, liver dysfunction. Pregnancy & lactation. Childn.

Adverse Reactions

Headache, edema, fatigue, somnolence, nausea, abdominal pain, skin redness, tachycardia, dizziness; itching, skin rash, dyspnea, dyspepsia, asthenia, myalgia, gingival hyperplasia, erythema multiforme. Rarely, MI, arrhythmia (ventricular tachycardia & atrial fibrillation) & chest pain.

View ADR Reporting Link

MIMS Class

Calcium Antagonists

ATC Classification

C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.

Regulatory Classification

Presentation/Packing

Form

Gracivask tab 10 mg

Packing/Price

3 × 10's

Form

Gracivask tab 5 mg

Packing/Price

3 × 10's

Gracivask

amlodipine

Manufacturer:

Gracia Pharmindo